ARCHIVES

NTP Board Approves $4 Million Mouse Variation Concept

This article is from The Cancer Letter archive.

Vol. 11 No. 45 | November 22, 1985

Download PDF Visit The Full Archive

Related Articles

House Bill Gives NCI $48 Mil. Less Than Clinton Requested

July 8, 1994

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

In Brief: White House Conservative Said Seeking Ouster Of Schweiker; Potter urges Greater Commitment

November 26, 1982

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985

NAB Report To President Makes Pitch for Money, Cites Research Progress

August 9, 1974

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001